Form Type: 4

SEC EDGAR Link
Accession Number:0001567619-21-017749
Date:2021-09-29
Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
Original Submission Date:

Reporting Person:

SMITH BRANDON S.
C/O PROTHENA BIOSCIENCES INC
331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 70.81 2021-09-29 deemed execution date A 25,000 (a) 2031-09-29 ordinary shares 25,000 $70.81 25,000 direct
Footnotes
IDfootnote
f1 the shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on september 29, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date.

Elevate your investments